Smart-Money SignalDistribution · 31/100— Insiders are net sellers over 90 days (-$22.4M, 18 sales vs 5 buys)
Revenue$610.8M
Net Income$210.5M
EPS$0.79
Market Cap$14.5B
Price Performance
Historical data including institutional events
Company Profile
M
Michael M. Morrissey
CEO & Executive Director
Exelixis, Inc. is a genomics-based drug discovery company located in Alameda, California, and the producer of Cometriq, a treatment approved by the U.S. Food and Drug Administration (FDA) for medullary thyroid cancer with clinical activity in several other types of metastatic cancer.
